一项随机对照研究,对患有非阻塞性冠状动脉疾病和冠状动脉微血管功能障碍的患者进行心脏康复的增强外部反推力
Yuanzhuo Zhang1, Xiaoyan Yin1, Lei Ren1
1Bengbu Medical College, Fuyang Peoples Hospital Affiliated to Bengbu Medical College.
International heart journal
|May 15, 2024
概括
增强的外部对冲动 (EECP) 与心脏康复 (CR) 结合,可显著改善非阻塞性冠状动脉疾病和冠状动脉微循环障碍患者的治疗结果,提供更安全,更有效的治疗选择.
科学领域:
- 心脏病学 心脏病学
- 血管医学 血管医学
- 康复疗法康复疗法康复疗法
背景情况:
- 冠状动脉微循环障碍 (CMD) 影响非阻塞性冠状动脉疾病 (NOCAD) 的患者.
- 增强的外部反推力 (EECP) 和心脏康复 (CR) 是冠状动脉心脏病的治疗方法.
- 在NOCAD患有CMD的患者中,EECP和CR的联合疗效尚未得到充分证实.
研究的目的:
- 研究在被诊断为NOCAD和CMD的患者中将EECP与CR结合的可行性和有效性.
- 为了比较EECP和CR联合治疗的治疗结果与单独CR的传统治疗.
主要方法:
- 在2021年1月至2022年6月期间,80名患有NOCAD和CMD (心肌 perfusion reserve <2.0) 的患者被录取.
- 患者被随机分为两个组:一个通常治疗组 (常规药物和CR) 和一个EECP治疗组 (标准治疗加EECP).
- 包括心脏功能指数,内皮功能标志物和心血管不良事件在内的结果在治疗前和治疗后进行了比较.
主要成果:
- 与常规治疗组相比,EECP与CR组结合的疗效率显著更高 (P <0.05).
- 关键指标,如左心室喷射分数,血氧化 (NO) 和血管内皮生长因子水平在EECP组显著改善.
- 在EECP治疗组中,心血管不良事件的发生率明显较低.
结论:
- 结合EECP和CR治疗为患有CMD症状的患者提供了卓越的疗效和安全性.
- 这种综合方法为治疗冠状动脉微循环障碍患者提供了宝贵的治疗参考.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...


